PolarityTE (PTEIQ) Stock Price, News & Analysis

Company Overview

PolarityTE, Inc., a clinical stage biotechnology company, develops and commercializes a range of regenerative tissue products and biomaterials for the fields of medicine, biomedical engineering, and material sciences in the United States. The company operates in two segments, Regenerative Medicine Products and Contract Services. It offers SkinTE, a tissue product used to repair, reconstruction, replacement, and supplementation of skin in patients for the treatment of acute or chronic wounds, burns, surgical reconstruction events, scar revision, or removal of dysfunctional skin grafts, as well as contract research services. The company also develops SkinTE Cryo allows multiple deployments from one original harvest through a cryopreservation process; SkinTE point-of-care device to permit the processing and deployment of SkinTE immediately following the initial harvest at the point-of-car; and other tissue regeneration products. PolarityTE, Inc. is headquartered in Salt Lake City, Utah.

Key Stats

• Today's Range: $0.11 to $0.13
• 50-Day Range: $0.03 to $0.13
• 52-Week Range: $0.05 to $0.09
• Volume: 1,223 shs
• Average Volume: 27,292 shs
• Market Capitalization: $923,052.00
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

PTEIQ Stock Analysis - Frequently Asked Questions

How have PTEIQ shares performed this year?

PolarityTE's stock was trading at $0.0840 at the beginning of the year. Since then, PTEIQ shares have increased by 50.1% and is now trading at $0.1261.
View the best growth stocks for 2024 here.

How do I buy shares of PolarityTE?

Shares of PTEIQ stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Company Calendar

• Today: 11/21/2024
• Fiscal Year End: 12/31/2024

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: Biotechnology
• Sub-Industry: Pharmaceutical Products
• Current Symbol: NASDAQ:PTEIQ
• CUSIP: N/A
• CIK: 1076682
• Web: www.polarityte.com
• Phone: (800) 560-3983
• Fax: 302-636-5454
• Employees: 60
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): ($3.28)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: $-7,830,000.00
• Net Margins: N/A
• Pretax Margin: -11,376.71%
• Return on Equity: -106.08%
• Return on Assets: -76.91%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 4.11
• Quick Ratio: 4.11

Sales & Book Value

• Annual Sales: $810,000.00
• Price / Sales: 1.14
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $2.30 per share
• Price / Book: 0.05

Miscellaneous

• Outstanding Shares: 7,320,000
• Free Float: 6,988,000
• Market Cap: $923,052.00
• Optionable: Not Optionable
• Beta: 0.92